Navigation Links
3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2008 Results
Date:3/11/2009

General and administrative expenses (7,379) (1,012) 192 (1) (7,187) (985) Total operating expenses (33,806) (4,635) (33,614) (4,608) Operating income 6,140 841 6,332 868 Other income/ (expenses), net Interest income 9,048 1,240 9,048 1,240 Interest expense (70) (10) (70) (10) Grant income 199 27 199 27 Others 299 41 299 41 Total other income, net 9,476 1,298 9,476 1,298 Income before Income tax expense and minority interests 15,616 2,139 15,808 2,166 Income tax credit/ (expense) 2,163 297 (2,739) (2) (576) (79) Income before minority interests 17,779 2,436 15,232 2,087 Minority interests, net of tax 116 15 116 16 Net income 17,895 2,451 15,348 2,103 Three Months Ended December 31, 2007 (unaudited), continued Actual Actual Adjustment Adjusted Adjusted GAAP GAAP Non-GAAP Non-GAAP RMB US$ RMB RMB US$ Net income Per share: Basic and diluted 0.12 0.02 0.10 0.01 Basic weighted average number of shares outstanding 152,099,155 152,099,155 152,099,155 152,099,155 Effect of dilutive potential shares 323,897 323,897
'/>"/>
SOURCE 3SBio Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related biology technology :

1. 3SBio Inc. Receives Official Recognition as a High-Tech Enterprise
2. 3SBio Inc. to Report 2008 Fourth Quarter and Full Year Earnings on March 11, 2009
3. 3SBio Inc. Appoints Mr. Bo Tan as Chief Financial Officer
4. 3SBio Inc. to Present at the Piper Jaffray 20th Annual Health Care Conference
5. 3SBio Inc. Announces Third Quarter 2008 Results
6. 3SBio Inc. Files for SFDA Approval of NuLeusin
7. 3SBio Inc. Announces Preliminary Third Quarter 2008 Results
8. 3SBio Inc. Schedules 2008 Third Quarter Earnings Release on Monday, November 10, 2008
9. 3SBio Inc. Files for SFDA Approval of High-dose (36,000 IU) EPIAO
10. 3SBio Inc. to Present at the UBS Global Life Sciences Conference
11. 3SBio Inc. Announces Results of Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email: